Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11913012 Cardiac cell reprogramming with myocardin and ASCL1

Patent 11913012 was granted and assigned to Tenaya Therapeutics on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Tenaya Therapeutics
Tenaya Therapeutics
0
Date Filed
March 24, 2021
0
Date of Patent
February 27, 2024
0
Patent Applicant
Tenaya Therapeutics
Tenaya Therapeutics
0
Patent Application Number
17211559
0
Patent Citations
‌
US Patent 6998115 Biodegradable poly(β-amino esters) and uses thereof
0
‌
US Patent 7070994 Packaging cells
0
‌
US Patent 7105345 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
0
‌
US Patent 7198951 Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor
0
‌
US Patent 7259151 AAV virions with decreased immunoreactivity and uses therefor
0
‌
US Patent 7427394 Biodegradable poly(β-amino esters) and uses thereof
0
‌
US Patent 7718424 AAV4 vector and uses thereof
0
‌
US Patent 7727969 Controlled release nanoparticle having bound oligonucleotide for targeted delivery
0
‌
US Patent 7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor
0
‌
US Patent 7867484 Heparin and heparan sulfate binding chimeric vectors
0
•••
Patent Inventor Names
Laura Lombardi
0
Huanyu Zhou
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11913012
0
Patent Primary Examiner
‌
Michael D Burkhart
0

Find more entities like US Patent 11913012 Cardiac cell reprogramming with myocardin and ASCL1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo